TORONTO | The first three companies selected to participate in the MaRS EXCITE program aim to improve outcomes for breast cancer, sleep apnea and drug-resistant hypertension.
For those who travel outside of the country in the coming months, we have a modest proposal: find a pub, sit down with locals and ask about their nation’s health care system.
